Medical Licensing (MD/DO) · Independent exam preparation
ABTS Primary Certification Part I: Surgical Decisions Guide Study Guide
Practise thoracic surgical decisions in lung cancer, pleural sepsis, valve disease, aortic emergencies and extracorporeal support for ABTS Part I.
By CertMedbry · Updated 19 October 2026
Practise deciding when to obtain tissue, assess operative reserve, control contamination, repair a valve, replace an aorta and troubleshoot extracorporeal support. These 60 selected concepts connect clinical mechanisms with operative decisions and common errors. The official ABTS written examination outline defines the full scope, including subjects beyond this selective guide: https://www.abts.org/ABTS/CertificationWebPages/Exam_Sequence/Written_Exam_Blueprint.aspx. Use the accompanying 20 questions and 20 flashcards to identify reasoning gaps, then study those topics in formal cardiothoracic references.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which certification examination does this guide cover?
It covers ABTS Primary Certification Part I (Written), the cognitive examination within initial thoracic surgery certification. The broader label 'American Board of Thoracic Surgery Examination' does not identify a separate examination. Initial certification also requires Part II (Oral); this guide does not simulate that oral examination.
ABTS Primary Certification Part I (Written) Examination · ABTS Examination Sequence
How many questions are described, and how many are scored?
The ABTS Part I detail page describes 250 multiple-choice questions. The cited official information does not identify a scored-versus-pretest allocation, so no such split is assumed.
What duration and 2026 examination dates are published?
The Part I detail page describes two equal sections of 2 hours 45 minutes, totaling 5½ hours of examination time. That page describes a single-day administration, while the current initial-certification page lists the 2026 written examination window as December 7–11. The window should not be interpreted as five days of testing for each candidate. The cited information does not establish additional appointment or break time.
ABTS Primary Certification Part I (Written) Examination · ABTS Training and Initial Certification
How is the examination delivered, and is it adaptive?
ABTS describes electronic delivery at Pearson Professional Testing Centers throughout the United States. Availability varies by center. The cited official pages do not establish adaptive delivery or an adaptive stopping rule.
Which item styles are described?
ABTS describes multiple-choice questions built from a brief statement or case history, sometimes with a graphic or picture, followed by possible answers. These learning drills use four-option single-best-answer questions. Their option count is a study format, not a claim about the official examination's option count.
Which blueprint and weighting ranges apply?
The linked Qualifying (Written) Exam Matrix assigns approximately 50% each to General Thoracic and Cardiac. Overall-examination ranges are Lung 20–30%, Trachea/Bronchi 3–10%, Pleura 5–10%, Mediastinum 5–10%, Esophagus 5–10%, Chest Wall/Diaphragm 1–8%, Acquired Heart Disease 25–35%, Congenital Heart Disease 5–10%, and General Management 10–20%. These are ranges rather than fixed quotas. The published matrix has no stated revision identifier or effective date.
ABTS Written Exam Blueprint · ABTS Training and Initial Certification
Which TNM edition should candidates use?
The current initial-certification page explicitly states ninth-edition TNM use for both written and oral examinations. The older Part I detail page still contains an eighth-edition notice. This guide follows the current initial-certification notice and avoids edition-sensitive stage-group exercises.
ABTS Training and Initial Certification · ABTS Primary Certification Part I (Written) Examination
How does this selective guide reflect the official scope?
The 60 concepts allocate 30 to General Thoracic and 30 to Cardiac: Lung 12; Trachea/Bronchi 3; Pleura 4; Mediastinum 3; Esophagus 5; Chest Wall/Diaphragm 3; Acquired Heart Disease 18; Congenital Heart Disease 4; General Management 8. The questions and flashcards each split 10:10 between the parent categories. Smaller domains require rounding. Selected topics include airway reconstruction, malignant effusion, pneumothorax, esophageal foreign bodies, congenital aortic lesions, conduction complications and treatment goals. The official outline remains the full scope; this guide does not exhaust congenital surgery, pacing, myocardial protection, arrhythmia surgery, transplantation, cardiomyopathy or ethics.
ABTS Written Exam Blueprint · ABTS Primary Certification Part I (Written) Examination
How should these materials relate to maintenance certification and clinical guidelines?
ABTS states that SESATS is a basis for its Maintenance of Certification examination and is not considered the primary reference guide for Part I. Use formal textbooks, journals and courses alongside this guide. Clinical references here retain their publication years, including the 2020 valve, 2022 aortic and 2021 blood-management guidance; their dates are distinct from the undated examination matrix.
ABTS Primary Certification Part I (Written) Examination · ACC Guidelines and Clinical Policy · STS Clinical Practice Documents and Policies
This independent guide targets the American Board of Thoracic Surgery Primary Certification Part I (Written) Examination, also called the qualifying written examination. It addresses physician specialty board certification in the United States. The learning questions are independently authored and are not official ABTS examination items or endorsed content.
Outline used: Undated ABTS Qualifying (Written) Exam Matrix, linked from the current initial-certification page and accessed 2026-10-10. The workbook label 'American Board of Thoracic Surgery Examination' broadly describes ABTS examinations; this MCQ preview maps specifically to the officially named Primary Certification Part I (Written) Examination. The assigned slug is preserved. ABTS initial certification also requires Part II (Oral). No blueprint revision number or effective date was stated on the opened matrix.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
General Thoracic: Lung20–30%
1.How does nodal location change lung cancer treatment planning?
N1 disease involves ipsilateral hilar, peribronchial or intrapulmonary nodes. N2 disease involves ipsilateral mediastinal or subcarinal nodes. N3 disease involves contralateral mediastinal or hilar nodes, or scalene or supraclavicular nodes on either side. These anatomical categories affect prognosis and treatment sequencing. Suspicious nodes generally require tissue assessment when their status would change management. Nodal involvement does not automatically exclude every surgical pathway: selected patients with resectable N2 disease may receive surgery within a planned multimodality strategy, whereas immediate resection of the primary alone may be inappropriate.
Apply it
A right upper-lobe primary with a malignant subcarinal node has N2 involvement, not N1 involvement. Establish the extent of mediastinal disease and discuss multimodality treatment before choosing the operative sequence. A contralateral hilar metastasis would instead represent N3 involvement.
Common pitfall: Do not classify all ipsilateral nodes as N1 or assume that technical removability establishes oncologic suitability for immediate surgery. Subcarinal nodes are N2, and supraclavicular nodes are N3 even when ipsilateral to the primary.
NCI Non-Small Cell Lung Cancer Treatment: Health Professional Version
2.Why can a PET-positive mediastinal node require tissue confirmation?
Fluorodeoxyglucose uptake reflects metabolic activity rather than malignancy alone. Inflammation and granulomatous disease can produce avid mediastinal nodes, while small malignant deposits may escape imaging detection. When a nodal finding would redirect curative treatment, invasive assessment can resolve this uncertainty. Endosonographic sampling or surgical staging should target relevant stations and be interpreted alongside imaging, sampling adequacy and the pretest probability of nodal involvement rather than as isolated binary results.
Apply it
A potentially operable lung cancer has an isolated avid mediastinal node in a patient with prior granulomatous infection. Obtain appropriate nodal sampling before using the scan alone to exclude a surgical treatment pathway.
Common pitfall: A positive scan is not histology, and a negative sample is not automatically definitive when the relevant station was inadequately sampled or suspicion remains high.
NCI Non-Small Cell Lung Cancer Treatment: Health Professional Version
3.When does brain imaging matter before curative lung cancer treatment?
An occult brain metastasis can change the intent and sequence of lung cancer treatment even when thoracic disease appears operable. Neurologic symptoms demand assessment, and brain imaging is also used in appropriate higher-stage staging pathways. Contrast-enhanced MRI is particularly useful for detecting intracranial disease. A reassuring thoracic PET study does not reliably exclude brain metastases because normal cerebral glucose uptake limits its usefulness for this specific purpose in clinical staging.
Apply it
A patient being assessed for curative treatment of locally advanced lung cancer reports new focal weakness. Obtain dedicated brain imaging before proceeding with the planned thoracic operation or assuming the symptoms are unrelated.
Common pitfall: Do not treat a negative body PET scan as sufficient intracranial staging. Symptoms and disease extent determine the need for dedicated brain assessment.
NCI Non-Small Cell Lung Cancer Treatment: Health Professional Version
4.Which findings suggest a superior sulcus tumor?
Superior sulcus tumors arise at the lung apex and may invade structures of the thoracic inlet. Shoulder or arm pain can reflect brachial plexus involvement, while sympathetic chain disruption can produce ipsilateral ptosis and miosis. The important distinction is between apical location and the actual extent of invasion. Evaluate neural, vertebral and vascular relationships together with nodal and distant disease before judging resectability or selecting a multimodality treatment sequence.
Apply it
A smoker presents with persistent shoulder pain, hand weakness and ipsilateral ptosis. An apical lung mass should trigger thoracic inlet assessment and complete staging before a decision about the feasibility and sequence of resection.
Common pitfall: Shoulder pain alone does not prove plexus invasion, and an apical tumor is not automatically unresectable. Define the involved structures and overall disease extent.
NCI Non-Small Cell Lung Cancer Treatment: Health Professional Version
5.Which patients resemble the CALGB 140503 sublobar-resection population?
CALGB 140503 evaluated sublobar resection against lobar resection for selected peripheral non-small-cell lung cancers measuring no more than 2 cm. Randomization followed intraoperative confirmation of node-negative disease. The trial therefore supports a carefully staged, anatomically limited population rather than every small-looking lung lesion. Tumor location, ability to obtain an adequate margin and reliable nodal evaluation remain central when translating its findings into an operative choice for an individual patient.
Apply it
A patient has a 1.6-cm peripheral lesion suitable for complete sublobar removal. Discuss sublobar resection only after considering margins and the nodal assessment that made the randomized trial population meaningfully different from unstaged small tumors.
Common pitfall: Do not extrapolate the trial to central lesions, larger tumors or known nodal disease. Small diameter alone does not reproduce its eligibility conditions.
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
6.How should the CALGB 140503 noninferiority result be interpreted?
The primary endpoint in CALGB 140503 was disease-free survival, and sublobar resection met the prespecified noninferiority criterion relative to lobectomy in the selected population. Noninferiority does not mean that the procedures are identical, that sublobar resection is superior or that every recurrence outcome is interchangeable. Overall survival and recurrence patterns provide additional context. Always connect a trial conclusion to its endpoint, eligibility conditions and operative-quality requirements before applying it.
Apply it
During consent, a patient asks whether the trial proves a smaller operation is better. Explain that it supports noninferior disease-free survival under defined conditions, while operative extent still depends on margins, nodes and anatomy.
Common pitfall: Do not convert 'noninferior for disease-free survival' into 'superior overall survival.' Different endpoints answer different clinical questions, even within the same randomized trial.
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
7.Why must pulmonary reserve assessment include more than spirometry?
Fitness for lung resection depends on ventilatory mechanics, gas transfer, the contribution of the lung being removed, exercise performance and cardiovascular status. A satisfactory FEV1 cannot exclude impaired diffusion or limited integrated cardiopulmonary reserve. The ERS/ESTS fitness framework includes split-function assessment, exercise evaluation, cardiac evaluation and prehabilitation. Interpret these domains together so that an anatomic treatment plan is matched to the patient's likely postoperative function rather than to one reassuring measurement.
Apply it
A patient has acceptable spirometry but marked exertional limitation and reduced gas transfer. Continue physiologic and cardiac assessment rather than clearing the patient for major resection from the FEV1 result alone at that visit.
Common pitfall: A single normal value does not establish operative fitness. Discordance between symptoms, gas transfer and spirometry should prompt explanation rather than selective reassurance.
ESTS Announcement of the ERS/ESTS Lung Cancer Fitness Guideline
8.How can split lung function estimate the effect of a planned resection?
Split-function assessment asks how much functioning lung will remain after the proposed resection. In an explicitly simplified proportional model, predicted postoperative FEV1 equals baseline FEV1 multiplied by one minus the fraction of function removed. This is an estimate under stated assumptions, not a complete risk assessment. Regional heterogeneity, exercise capacity, diffusion, comorbidity and the planned operation can change the clinical interpretation even when the arithmetic is straightforward and internally correct.
Apply it
Assume baseline FEV1 is 2.40 L and the planned resection removes 40% of measured function. Using the proportional model gives 2.40 × 0.60 = 1.44 L; then integrate the estimate with the remaining assessment.
Common pitfall: Do not subtract a percentage as though it were liters, or treat an estimated postoperative value as a stand-alone authorization for major resection.
ESTS Announcement of the ERS/ESTS Lung Cancer Fitness Guideline
9.How do pulmonary function and exercise testing guide lung-resection decisions?
Measure baseline FEV1 and DLCO because airflow limitation and impaired gas transfer represent different physiological deficits. Estimate predicted postoperative function for the proposed resection, accounting for the functional contribution of the tissue removed. Exercise assessment helps clarify integrated reserve when resting measurements or functional performance are concerning. CPET measures peak oxygen uptake and ventilatory efficiency. The [2025 ERS/ESTS guideline](https://publications.ersnet.org/content/erj/66/5/2500156) identifies peak oxygen uptake below 12 mL/kg/min as an indicator of increased postoperative risk, while emphasizing uncertainty about a clear high-risk cutoff. This value does not establish inoperability.
Apply it
A patient with reduced predicted postoperative function has peak oxygen uptake of 11 mL/kg/min. Explain the increased operative risk, assess potentially reversible cardiac or conditioning limitations, and consider prehabilitation. Compare the expected oncologic benefit and physiological burden of the proposed resection with appropriate alternatives.
Common pitfall: Normal resting oxygen saturation does not establish adequate exercise reserve. Conversely, an abnormal CPET value is not an automatic prohibition against surgery. Interpret it alongside predicted postoperative function, resection extent, comorbidities and expected treatment benefit; do not present 12 mL/kg/min as a precisely validated boundary separating operable from inoperable patients.
ESTS Announcement of the ERS/ESTS Lung Cancer Fitness Guideline
10.Why is cardiac evaluation part of lung cancer fitness assessment?
Lung resection imposes cardiovascular as well as respiratory stress. Symptoms such as exertional chest discomfort, syncope or unexplained breathlessness may indicate cardiac disease that changes perioperative risk and treatment timing. The ERS/ESTS fitness framework includes cardiac assessment because pulmonary measurements cannot establish coronary, valvular or ventricular safety. Investigate clinically meaningful findings and integrate cardiac status with pulmonary reserve and expected cancer benefit before choosing the extent and sequence of treatment.
Apply it
An otherwise operable patient reports exertional chest pressure despite preserved spirometry. Clarify the cardiac diagnosis before elective lung resection, because a favorable pulmonary assessment does not resolve the separate risk suggested by these symptoms.
Common pitfall: Do not label all dyspnea in a smoker as pulmonary. An unexplained cardiac symptom remains relevant even when the proposed surgery is thoracic.
ESTS Announcement of the ERS/ESTS Lung Cancer Fitness Guideline
11.How does prehabilitation fit into curative lung cancer treatment?
Prehabilitation addresses modifiable limitations before treatment rather than merely assigning a risk category. The ERS/ESTS framework recognizes it within fitness assessment for curative-intent lung cancer care. Match optimization to identified problems and coordinate it with the oncologic timetable. Improvement in conditioning may support treatment tolerance, but prehabilitation does not erase fixed physiologic disease or justify ignoring an unfavorable risk-benefit balance when choosing an operation for a particular patient.
Apply it
A patient with potentially curable cancer is markedly deconditioned but has no immediate oncologic emergency. Arrange targeted prehabilitation alongside staging and treatment planning, then reassess relevant functional limitations without creating an indefinite delay in definitive care.
Common pitfall: Do not present prehabilitation as a guaranteed conversion to operability. It targets modifiable reserve and must fit the patient's cancer timeline and underlying disease.
ESTS Announcement of the ERS/ESTS Lung Cancer Fitness Guideline
12.When is stereotactic radiation relevant to early lung cancer?
Stereotactic body radiation therapy delivers focused, high-dose radiation to a defined tumor target and is an important curative-intent option for selected early-stage lung cancers when surgery cannot be performed. Treatment choice still requires staging and attention to tumor location and surrounding structures. Distinguish medical inoperability from an anatomically unresectable tumor: both can prevent surgery, but they describe different problems and may lead to different radiation or multimodality strategies.
Apply it
A patient has a small localized lung cancer but severe cardiopulmonary disease makes resection unsuitable. Discuss stereotactic radiation as an active treatment option after staging and radiation-planning assessment, rather than assuming only observation remains available.
Common pitfall: Do not equate inability to tolerate surgery with absence of curative options. Conversely, a radiation option does not remove the need for staging.
General Thoracic: Trachea/Bronchi3–10%
13.When should persistent air leakage suggest a major airway injury?
A major tracheobronchial disruption can prevent lung re-expansion despite a correctly positioned pleural drain. A large persistent air leak, pneumomediastinum, subcutaneous emphysema or respiratory difficulty after trauma should raise suspicion. CT helps define associated injuries, while bronchoscopy directly evaluates airway continuity and injury location. Confirm drainage-system integrity, but do not allow repeated tube adjustments to delay recognition of a structural airway lesion that needs a specific management plan.
Apply it
After blunt trauma, a chest drain is correctly positioned but the lung remains collapsed with continuous major air loss. Assess the airway with bronchoscopy while coordinating ventilation and surgical expertise for a possible bronchial disruption.
Common pitfall: Persistent pneumothorax does not always mean the drain is too small. A major airway defect can maintain the leak despite adequate pleural drainage.
14.How should airway control account for a traumatic bronchial tear?
Airway control must provide ventilation without extending a tear or directing excessive gas through the defect. Bronchoscopic guidance helps identify the injury and, when feasible, position an airway device beyond it or isolate the injured side. The strategy depends on lesion location and associated injuries. Repeated blind instrumentation can worsen disruption, while indiscriminate increases in airway pressure may enlarge leakage without correcting effective ventilation of the uninjured lung tissue.
Apply it
A ventilated trauma patient has a suspected main bronchial tear and worsening air loss. Use bronchoscopic assessment to guide a location-specific airway strategy rather than repeatedly advancing the tube blindly or simply increasing ventilator pressures.
Common pitfall: A tube that enters the trachea is not necessarily safely positioned relative to the injury. Define the defect before relying on routine ventilation adjustments.
15.When can bronchial sleeve resection preserve lung in central cancer?
Sleeve resection removes an involved bronchial segment and reconstructs airway continuity, allowing selected central tumors to be removed while preserving uninvolved lung. Selection requires an oncologically complete resection and a viable reconstruction. Define bronchial extent, nodal disease and pulmonary reserve before choosing between sleeve lobectomy and a more extensive resection. Preserving parenchyma is valuable only when adequate tumor clearance remains achievable.
Apply it
A central lobar tumor involves the adjacent bronchus, but uninvolved distal lung can be preserved with clear bronchial margins. Assess sleeve reconstruction rather than assuming pneumonectomy is necessary.
Common pitfall: Do not accept residual tumor merely to preserve lung or infer sleeve feasibility from tumor diameter alone.
NCI Non-Small Cell Lung Cancer Treatment: Health Professional Version
General Thoracic: Pleura5–10%
16.When does pleural infection require drainage?
Frank pleural pus establishes empyema and requires drainage. In a nonpurulent parapneumonic effusion, pleural fluid pH of 7.2 or lower indicates high risk of complicated infection and supports drain insertion when an accessible collection is present. Intermediate results require integration with biochemical, imaging and clinical findings. Antibiotics treat infection but cannot reliably evacuate an established infected collection. Interpret pH using a properly collected sample because contamination can alter the result.
Apply it
A patient with pneumonia remains febrile and has an accessible effusion with pleural pH 7.08. Add pleural drainage to antimicrobial treatment rather than waiting for antibiotics alone to sterilize an established complicated collection.
Common pitfall: Do not wait for visibly purulent fluid before draining a complicated infection. A low pH can identify a drainage indication before pus develops.
British Thoracic Society Guideline for Pleural Disease, July 2023
17.How does lung expansion guide malignant pleural effusion treatment?
Pleurodesis depends on contact between the visceral and parietal pleural surfaces. A symptomatic malignant effusion with expandable lung permits a choice of an indwelling pleural catheter or pleurodesis. Substantial non-expandable lung prevents reliable apposition, making an indwelling catheter a more suitable drainage strategy. The BTS guideline favors a catheter over talc pleurodesis when more than 25% of the lung remains non-apposed. Symptom response to drainage and patient preferences also inform the choice.
Apply it
Drainage relieves dyspnea, but imaging shows substantial persistent non-expansion. Discuss an indwelling catheter for ongoing symptom control rather than expecting talc to overcome the absent pleural contact.
Common pitfall: Successful fluid evacuation does not establish pleurodesis suitability. Confirm whether the lung expands and whether drainage actually improves the patient's symptoms.
British Thoracic Society Guideline for Pleural Disease, July 2023
18.When can combined intrapleural tPA and DNase help?
Combined tissue plasminogen activator and DNase can be considered when initial chest-tube drainage has ceased and a residual infected collection remains. The agents address different barriers: fibrinous septations and viscous DNA-rich material. Their combined use differs from administering either drug alone. Assess bleeding risk and discuss that complication before treatment. The decision belongs within an ongoing source-control strategy, with clinical and imaging reassessment to determine whether drainage is becoming effective.
Apply it
A patent pleural catheter has stopped draining, but imaging shows substantial residual loculated infection. Consider combined intrapleural therapy after reviewing bleeding risk, while continuing to assess whether the patient instead needs operative source control.
Common pitfall: Do not assume a single fibrinolytic reproduces the evidence for combined therapy. Also, intrapleural treatment cannot compensate for a catheter outside the collection.
British Thoracic Society Guideline for Pleural Disease, July 2023
19.When should spontaneous pneumothorax prompt recurrence-prevention surgery?
Consider elective recurrence-prevention surgery after a second ipsilateral or first contralateral spontaneous pneumothorax. Earlier surgery can be appropriate when preventing recurrence is especially important, including selected high-risk occupations. The operative components address different mechanisms: bullectomy removes a potential source of air leakage, while pleurodesis promotes adhesion between pleural surfaces to reduce the opportunity for another pneumothorax. Discuss recurrence risk, operative burden and the patient's priorities after the acute episode has been managed.
Apply it
After resolution of a second right-sided spontaneous pneumothorax, discuss definitive recurrence prevention rather than repeating drainage alone as the entire long-term plan.
Common pitfall: Current lung re-expansion establishes resolution of the present episode, not elimination of future recurrence risk. Distinguish acute drainage from an intervention intended to prevent another episode.
British Thoracic Society Guideline for Pleural Disease, July 2023
General Thoracic: Mediastinum5–10%
20.Why should thymoma prompt assessment for myasthenia gravis?
Thymoma is associated with autoimmune disease, especially myasthenia gravis. Fatigable ocular, bulbar or limb weakness suggests impaired neuromuscular transmission and has direct perioperative implications. Bulbar dysfunction can threaten airway protection, while respiratory weakness may complicate anesthesia and postoperative recovery. Assess symptoms and arrange appropriate evaluation before thymoma treatment. The systemic disorder is clinically important even when the mediastinal tumor itself appears localized and technically straightforward to remove completely.
Apply it
A patient with an anterior mediastinal mass reports evening diplopia and difficulty chewing late in meals. Evaluate for myasthenia and address respiratory or bulbar involvement before scheduling an otherwise routine-appearing thymoma resection under general anesthesia.
Common pitfall: Do not attribute fatigability to anxiety or tumor bulk alone. A small thymoma can coexist with clinically significant neuromuscular disease that alters perioperative planning.
21.Which blood and immune abnormalities can accompany thymoma?
Thymoma can accompany pure red cell aplasia and hypogammaglobulinemia as well as myasthenia gravis. Pure red cell aplasia selectively impairs erythroid production, producing anemia with an inadequate reticulocyte response rather than uniform suppression of all marrow cell lines. Hypogammaglobulinemia can present through recurrent infections. These associations make unexplained anemia and infection relevant to mediastinal assessment and perioperative planning, rather than unrelated findings to dismiss once the mass is identified.
Apply it
A patient with thymoma has severe anemia, low reticulocytes and relatively preserved leukocytes and platelets. Investigate selective erythroid failure; if recurrent infections are also present, assess for an associated immune deficiency before definitive treatment planning.
Common pitfall: Do not assume all anemia near cancer is blood loss or generalized marrow invasion. The pattern of affected cell lines provides a discriminating clue.
22.How does complete resectability shape thymoma treatment?
Surgery is central for a thymoma that can be completely resected. Treatment planning must distinguish a localized removable mass from invasion that makes an immediate complete operation unlikely. Histology, extent and expected completeness of resection guide the role and sequence of radiation or systemic therapy. The key principle is an oncologically complete strategy rather than a debulking operation chosen simply because some portion of the tumor is accessible to the surgeon.
Apply it
Imaging shows a thymic tumor closely involving major mediastinal structures. Assess whether complete resection is realistic and discuss a multimodality sequence before undertaking an operation likely to leave substantial disease behind in a fit patient.
Common pitfall: Do not equate exposure of a mediastinal mass with oncologic resectability. Expected margin status and invasion influence whether surgery should occur first at all.
General Thoracic: Esophagus5–10%
23.Which esophageal foreign bodies require emergent endoscopic removal?
WSES recommends emergent flexible endoscopy, preferably within 2 hours and no later than 6 hours, for sharp objects, batteries, magnets or complete esophageal obstruction. Inability to handle secretions signals complete obstruction and aspiration risk. Sharp objects threaten perforation, while batteries can rapidly injure tissue. Airway protection and procedural planning must accompany removal; suspected perforation or proximity to vital structures changes the need for surgical involvement.
Apply it
A patient cannot swallow saliva after food impaction. Arrange emergent endoscopic relief with airway assessment rather than waiting for routine next-day endoscopy.
Common pitfall: Hemodynamic stability does not make complete obstruction safe to observe. Inability to manage secretions remains an urgent aspiration and obstruction warning.
24.Which esophageal perforations may be managed nonoperatively?
The WSES selection framework requires stability, early presentation within 24 hours, specified as less than 24 hours in its table, and absence of signs or symptoms of sepsis. Favorable anatomy includes a cervical or thoracic perforation contained by surrounding tissues, an intramural injury or minimal periesophageal contrast leakage draining back into the esophagus, and no massive pleural contamination. There should be no preexisting esophageal disease. Close expert surveillance and immediate, round-the-clock surgical and radiological intervention must be available. Treatment includes withholding oral intake, antimicrobials, nutritional support and drainage when required.
Apply it
A patient presents 8 hours after injury with a contained cervical leak draining into the lumen, no sepsis, no underlying esophageal disease and minimal contamination. Consider active nonoperative treatment where expert monitoring and immediate intervention are available.
Common pitfall: Stability and containment alone are insufficient. Sepsis, preexisting obstruction or other esophageal disease, unfavorable drainage or major contamination undermine this selection framework.
25.Why does closing an esophageal defect not complete source control?
Esophageal perforation releases saliva, gastric contents and organisms into adjacent spaces. Closure, endoscopic sealing or another defect-directed intervention stops further leakage but does not remove material already contaminating the mediastinum or pleura. Effective treatment therefore combines resuscitation, antimicrobial therapy, drainage or debridement, leak control and nutritional support as indicated. Tissue viability, defect characteristics and underlying esophageal disease influence whether repair, endoscopic treatment or a more extensive operation is appropriate.
Apply it
A thoracic perforation is successfully sealed endoscopically, but a large infected pleural collection remains. Arrange drainage and reassess for debridement rather than judging treatment complete from the absence of further contrast leakage on imaging.
Common pitfall: A technically successful seal can coexist with uncontrolled sepsis. Evaluate the contaminated spaces and physiological response, not merely the appearance of the esophageal defect.
26.Why does type III achalasia favor a tailored longer myotomy?
Achalasia combines impaired esophagogastric junction relaxation with abnormal esophageal motor function. Type III includes spastic contractions, so treatment limited to the sphincter may leave a clinically important proximal spastic segment untreated. High-resolution manometry defines the pattern and helps tailor myotomy length. Peroral endoscopic myotomy is particularly useful when a longer myotomy is needed. Before treatment, endoscopic assessment also helps exclude mechanical obstruction or malignancy mimicking a primary motility disorder.
Apply it
A patient has dysphagia, no obstructing lesion at endoscopy and manometric type III achalasia extending proximally. Select a treatment capable of covering the spastic segment rather than planning a short sphincter-only disruption by default.
Common pitfall: Do not choose myotomy length solely from the gastroesophageal junction location. In spastic achalasia, the clinically relevant motor abnormality may extend substantially farther proximally.
ACG Clinical Guidelines: Diagnosis and Management of Achalasia, 2020
27.How should reflux risk influence achalasia treatment?
Disrupting the lower esophageal sphincter relieves outflow obstruction but weakens an antireflux barrier. Adding fundoplication to surgical myotomy reduces postoperative acid exposure compared with myotomy alone. Peroral endoscopic myotomy does not include the same surgical antireflux construction and carries an important reflux burden. Discuss this trade-off before treatment and evaluate persistent or recurrent symptoms carefully, because heartburn, retained contents and recurrent obstruction can produce overlapping complaints after an intervention.
Apply it
A patient comparing laparoscopic myotomy with fundoplication and peroral endoscopic myotomy prioritizes minimizing reflux. Explain the antireflux benefit of fundoplication alongside the ability to tailor myotomy, and plan appropriate follow-up for post-treatment symptoms.
Common pitfall: Do not assume relief of dysphagia proves reflux is absent. Conversely, recurrent symptoms after myotomy should not automatically be labeled reflux without appropriate evaluation.
ACG Clinical Guidelines: Diagnosis and Management of Achalasia, 2020
General Thoracic: Chest Wall/Diaphragm1–8%
28.When should trauma raise suspicion for diaphragmatic injury?
Diaphragmatic injury may follow blunt force or penetrating trauma crossing the thoracoabdominal boundary. Small defects can be difficult to identify initially, yet later permit abdominal viscera to herniate into the chest. CT findings and wound trajectory inform suspicion, while laparoscopy or thoracoscopy may be necessary when concern persists despite nondiagnostic imaging. A normal early radiograph cannot reliably exclude a small injury in a patient with a strongly suggestive mechanism or trajectory.
Apply it
A stable patient has a penetrating left lower-chest wound and no obvious hernia on initial imaging. Evaluate the wound trajectory and consider direct minimally invasive inspection when diaphragmatic injury remains plausible despite the reassuring initial appearance.
Common pitfall: Do not require visible intrathoracic bowel to suspect a tear. Herniation may be delayed, and small traumatic defects can escape initial imaging detection.
29.Why should a diagnosed traumatic diaphragm defect be repaired?
A traumatic diaphragmatic defect creates a persistent path between abdomen and thorax. Pressure differences and movement can promote delayed visceral herniation, with possible obstruction, strangulation and respiratory compromise. Once identified, repair is indicated when the patient's condition permits, with assessment of associated injuries and herniated-organ viability. The approach depends on physiology and accompanying trauma. Repair prevents future consequences of the opening rather than merely correcting the patient's current chest imaging appearance.
Apply it
Laparoscopy identifies a traumatic diaphragm tear without current bowel herniation. Repair the defect and inspect associated injuries instead of leaving it untreated because the abdominal organs remain below the diaphragm at that particular moment.
Common pitfall: Absence of present herniation does not make an established traumatic defect harmless. The untreated communication can cause delayed, potentially life-threatening visceral complications later.
30.Which complications should be distinguished after traumatic diaphragm repair?
Recognized complications include empyema, subphrenic abscess, suture dehiscence and hemidiaphragm paralysis from phrenic nerve injury. Empyema involves infection of the pleural space; a subphrenic abscess is an infected collection beneath the diaphragm. Suture dehiscence compromises repair integrity and can permit recurrent herniation. Phrenic injury impairs active diaphragmatic contraction even when the closure remains intact. The WSES-AAST guideline recommends a chest tube after diaphragm repair to drain the pleural space and support lung expansion.
Apply it
Fever and a loculated pleural collection suggest empyema, whereas an infected collection below the diaphragm suggests subphrenic abscess. Recurrent intrathoracic abdominal contents raise concern for suture dehiscence. An elevated hemidiaphragm with reduced or paradoxical motion suggests diaphragmatic dysfunction and possible phrenic injury. Assess chest-drain position and patency when pleural air or fluid persists.
Common pitfall: An elevated hemidiaphragm alone does not distinguish repair failure from paralysis. Evaluate anatomical continuity and diaphragmatic movement separately. Likewise, a functioning chest tube does not exclude a subphrenic abscess: pleural drainage does not necessarily drain an abdominal collection.
Cardiac: Acquired Heart Disease25–35%
31.Why is an internal thoracic artery preferred for the LAD?
The STS arterial-conduit guideline recommends an internal thoracic artery for the left anterior descending coronary artery when LAD bypass is indicated. Its durable performance makes this graft-target pairing central to coronary surgery. Conduit planning still requires assessment of target quality, inflow and patient-specific constraints. Distinguish the strong rationale for an internal thoracic artery to the LAD from a blanket assumption that every additional arterial graft offers the same benefit in every configuration.
Apply it
A patient undergoing multivessel CABG has a suitable LAD target and usable internal thoracic artery. Plan that arterial graft for the LAD, then select additional conduits according to target stenosis, anatomy and patient-specific risks.
Common pitfall: Do not choose all conduits solely for harvesting convenience. The conduit-target pairing has long-term implications, particularly for the LAD territory in coronary bypass surgery.
STS Clinical Practice Guidelines on Arterial Conduits for CABG, 2016
32.Which assessments matter before radial artery harvest?
Radial artery use requires confidence that the hand will remain adequately perfused through the remaining circulation after harvest. Assess collateral supply and the conduit itself before committing to removal. Relevant prior instrumentation, vascular disease and potential future access needs also influence suitability. A useful coronary target does not make every radial artery an acceptable conduit. The decision combines donor-limb safety with expected graft performance and the patient's broader vascular and treatment context.
Apply it
A radial graft is being considered for a severely stenosed coronary target. Before harvest, evaluate hand collateral perfusion and radial suitability, including relevant vascular history, rather than treating the presence of a palpable pulse as sufficient.
Common pitfall: A palpable radial pulse demonstrates current inflow, not adequate post-harvest collateral perfusion. Donor-limb safety must be assessed before selecting the conduit for bypass.
STS Clinical Practice Guidelines on Arterial Conduits for CABG, 2016
33.How does competitive flow affect an arterial coronary graft?
An arterial graft performs poorly when substantial native coronary flow competes with graft flow through a moderately narrowed target. Reduced graft demand can contribute to low flow and failure, particularly with a radial artery conduit. The STS guideline therefore links radial graft use to severe target stenosis. Match conduit selection to the functional and anatomic significance of the native lesion rather than assuming an arterial conduit will overcome an unsuitable target.
Apply it
Two potential targets have markedly different stenosis severity. When selecting a radial graft destination, favor the appropriately severe lesion rather than a moderate narrowing with substantial preserved native flow, assuming the other anatomical requirements are satisfactory.
Common pitfall: Do not interpret every poorly functioning arterial graft as a technical anastomotic error. Competitive native flow can undermine performance despite a technically sound connection.
STS Clinical Practice Guidelines on Arterial Conduits for CABG, 2016
34.How should bilateral internal thoracic grafting account for sternal risk?
Using both internal thoracic arteries may provide additional arterial revascularization but can compromise sternal perfusion and increase wound risk in susceptible patients. Selection should therefore account for factors such as diabetes and other contributors to poor healing. The STS guideline identifies measures including skeletonized harvest, glycemic control, smoking cessation and enhanced sternal stabilization where appropriate. Conduit durability and sternal safety must be considered together rather than as unrelated operative choices.
Apply it
A patient with diabetes and other wound-risk factors is being considered for bilateral internal thoracic grafting. Compare the expected revascularization benefit with sternal risk and consider protective harvest and stabilization strategies or an alternative second conduit.
Common pitfall: Do not assume a second internal thoracic artery is universally preferable. A durable graft strategy can still produce avoidable harm if sternal vulnerability is ignored.
STS Clinical Practice Guidelines on Arterial Conduits for CABG, 2016
35.When does severe aortic stenosis require intervention?
High-gradient severe aortic stenosis has a peak aortic jet velocity of at least 4 m/s or a mean gradient of at least 40 mm Hg; valve area is typically 1.0 cm² or less. Symptoms attributable to confirmed severe stenosis indicate intervention. Asymptomatic severe stenosis with LVEF below 50% is also an intervention indication. In selected asymptomatic patients at low surgical risk, additional reasons to consider intervention include very severe stenosis with velocity at least 5 m/s, an abnormal exercise test, BNP above three times normal, or velocity progression of at least 0.3 m/s annually.
Apply it
A patient with velocity 4.3 m/s, mean gradient 45 mm Hg and exertional syncope attributable to stenosis needs valve-intervention assessment. A genuinely asymptomatic patient with confirmed severe stenosis and LVEF 45% also meets an intervention indication.
Common pitfall: A small calculated valve area with a low gradient requires confirmation rather than automatic classification as high-gradient disease. Check measurement accuracy and flow; low-dose dobutamine echocardiography in reduced-LVEF low-flow disease or CT valve-calcium assessment can help distinguish truly severe stenosis from apparent severity caused by low flow.
2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 1
36.How should aortic valve replacement approach be selected?
For patients who need replacement and are appropriate bioprosthetic candidates, the 2020 ACC/AHA framework favors surgical aortic valve replacement below age 65 or when life expectancy exceeds 20 years. For symptomatic patients aged 65–80 with suitable transfemoral anatomy, either surgical replacement or transfemoral transcatheter implantation is recommended after shared decision-making. Transfemoral TAVI is preferred above age 80 or when life expectancy is below 10 years, when anatomically feasible. These boundaries guide a broader assessment of operative risk, expected benefit, prosthesis durability, future interventions and patient preferences.
Apply it
A symptomatic 72-year-old with suitable transfemoral anatomy may reasonably choose either approach after discussion. A patient who also requires ascending aortic replacement has an associated surgical indication that strongly favors a combined surgical strategy.
Common pitfall: Apply these age boundaries within their clinical context. They do not replace assessment of transfemoral access, valve anatomy, concomitant coronary or aortic surgery, or lifetime treatment goals. Determine whether a bioprosthesis is appropriate before applying this replacement-route framework.
2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 1
37.Why is durable repair preferred for degenerative mitral regurgitation?
Primary degenerative mitral regurgitation arises from structural valve disease, such as prolapse or flail of a leaflet. When a durable successful repair is feasible, surgical repair is preferred to replacement. The operation corrects the lesion while preserving the native valve apparatus. Predictability and durability are essential: a technically possible repair is not necessarily a good repair. Distinguish this structural disease from secondary regurgitation caused principally by ventricular remodeling or altered geometry.
Apply it
A symptomatic patient has severe regurgitation from an isolated repairable posterior-leaflet flail. Recommend assessment for durable surgical repair rather than default replacement, assuming operative candidacy and the expected repair result are favorable in that setting.
Common pitfall: Do not transfer a repair recommendation mechanically to every mitral mechanism. Ventricular secondary regurgitation requires a different treatment framework from isolated degenerative leaflet disease.
2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 2
38.Why is an ejection fraction of 60% concerning in severe primary mitral regurgitation?
In severe mitral regurgitation, the ventricle ejects partly into the relatively low-pressure left atrium. The measured ejection fraction can therefore appear preserved despite emerging contractile impairment. The 2020 ACC/AHA guideline recommends surgery for asymptomatic severe primary regurgitation when LVEF is 60% or lower or LV end-systolic diameter is at least 40 mm. These thresholds identify ventricular consequences before conventional heart-failure values would necessarily appear in this loading condition.
Apply it
An asymptomatic patient with severe degenerative regurgitation has LVEF 58%. Recognize that this crosses a disease-specific ventricular threshold and assess for intervention rather than reassuring the patient that the value is nearly normal.
Common pitfall: Do not import ordinary ejection-fraction reassurance into severe mitral regurgitation. Its altered loading conditions make a seemingly preserved value compatible with clinically important dysfunction.
2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 2
39.Why is heart-failure treatment foundational in secondary mitral regurgitation?
Secondary mitral regurgitation commonly reflects ventricular dilation, leaflet tethering and altered closing forces rather than a primary leaflet defect. Guideline-directed heart-failure treatment addresses the underlying ventricular process and can reduce regurgitation. Appropriate device therapy also matters when indicated. Reassess symptoms and valve severity after optimization before selecting a valve intervention. Treating the regurgitant orifice without considering the ventricular disease risks applying a primary-valve solution to a fundamentally different mechanism.
Apply it
A patient with dilated cardiomyopathy has severe secondary regurgitation but incomplete heart-failure therapy. Optimize the ventricular treatment and reassess before assuming immediate isolated mitral surgery offers the best next step for symptom relief and prognosis.
Common pitfall: Do not equate a severe Doppler jet with an automatic surgical indication. Mechanism, optimized therapy, ventricular status and expected benefit determine the intervention pathway.
2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 2
40.Which ventricular secondary mitral regurgitation patients fit transcatheter repair criteria?
The [official 2020 ACC/AHA valve guideline slide set](https://www.heart.org/-/media/phd-files-2/science-news/2/2020/2020_acc_aha_guideline_for_the_management_of_patients_with_valvular_heart_disease_slide_set.pdf) specifies that transcatheter edge-to-edge repair is reasonable for selected patients with chronic severe secondary mitral regurgitation related to left ventricular systolic dysfunction. Patients should have persistent NYHA class II–IV symptoms despite optimized guideline-directed heart-failure therapy, suitable anatomy on transesophageal echocardiography, LVEF 20–50%, LV end-systolic diameter no greater than 70 mm, and pulmonary artery systolic pressure no greater than 70 mm Hg. Regurgitation severity alone does not establish eligibility.
Apply it
A persistently symptomatic patient receiving optimized therapy has severe ventricular secondary regurgitation, LVEF 35%, LV end-systolic diameter 62 mm and pulmonary artery systolic pressure 70 mm Hg. The pressure meets the inclusive boundary; confirm suitable valve anatomy and the remaining clinical conditions.
Common pitfall: The pulmonary-pressure criterion includes exactly 70 mm Hg. Meeting that boundary does not compensate for unsuitable anatomy, insufficient heart-failure treatment or ventricular measurements outside the recommended selection profile.
41.Which anticoagulation targets apply to mechanical heart valves?
Mechanical valves require vitamin K antagonist anticoagulation. Target INR is 3.0 for mechanical mitral replacement and 2.5 for a bileaflet or current-generation single-tilting-disc mechanical aortic prosthesis without additional thromboembolic risk. The aortic target becomes 3.0 with an older-generation prosthesis or added risk such as hypercoagulability, LV dysfunction or prior thromboembolism. A separate prosthesis-specific exception permits consideration of INR 1.5–2.0 for an On-X aortic valve without thromboembolic risk factors, beginning at least 3 months after surgery and combined with aspirin 75–100 mg daily. Direct oral anticoagulants are contraindicated for mechanical prostheses.
Apply it
A patient with a mechanical mitral valve requests a direct oral anticoagulant. Continue vitamin K antagonist treatment with target INR 3.0; the lower-intensity On-X aortic exception does not apply to a mechanical mitral valve.
Common pitfall: Distinguish a target INR from its therapeutic range. Do not generalize the On-X aortic exception to other prostheses or omit its timing, risk and aspirin conditions.
2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 3
42.Which infective-endocarditis findings indicate early surgery, and which support weaker recommendations?
Early surgery means intervention during the initial hospitalization before completion of the antibiotic course. The [2020 ACC/AHA official guideline slide set](https://www.heart.org/-/media/phd-files-2/science-news/2/2020/2020_acc_aha_guideline_for_the_management_of_patients_with_valvular_heart_disease_slide_set.pdf) gives Class I recommendations for valve dysfunction causing heart-failure symptoms; left-sided infection caused by S. aureus, fungi or highly resistant organisms; invasive destruction such as annular or aortic abscess, heart block or destructive penetrating lesions; and persistent bacteremia or fever lasting more than five days despite appropriate antimicrobial therapy. Early surgery is reasonable for recurrent emboli with persistent vegetations despite appropriate antibiotics, a Class IIa recommendation. For native left-sided disease with a mobile vegetation greater than 10 mm, with or without an embolic event, early surgery may be considered, a weaker Class IIb recommendation.
Apply it
Acute severe regurgitation with pulmonary edema represents a heart-failure indication for early surgery; completing antibiotics first is not required. Persistent positive cultures after six days of appropriate treatment independently meet the persistent-infection criterion. An isolated 12-mm mobile native-valve vegetation without these complications warrants individualized consideration under the weaker recommendation.
Common pitfall: Do not assign identical urgency or recommendation strength to every vegetation. Recurrent embolization despite treatment differs from vegetation size alone. Conversely, valve destruction, invasive infection or persistent bacteremia should not be reduced to nonspecific reasons merely to consider surgery.
2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 3
43.Why does acute type A dissection usually require immediate surgery?
Acute dissection involving the ascending aorta threatens rupture, tamponade, acute aortic regurgitation and coronary or branch-vessel compromise. The 2022 ACC/AHA guideline recommends immediate surgical intervention for acute type A dissection. Anti-impulse treatment and resuscitation support the patient while definitive care is organized; they do not eliminate the ascending aortic hazard. Malperfusion and neurologic findings inform the operative strategy but do not turn routine medical observation into the standard treatment.
Apply it
CT shows an acute ascending aortic dissection in a patient with abrupt chest pain. Activate emergency aortic surgery and initiate appropriate stabilization rather than adopting the surveillance approach used for an uncomplicated descending-only dissection.
Common pitfall: Do not let temporary pain relief imply resolution of risk. Ascending aortic involvement remains a surgical emergency even when initial blood pressure control succeeds.
2022 ACC/AHA Aortic Disease Guideline: Key Perspectives, Part 2
44.Which type B dissection features change medical management to intervention?
Uncomplicated acute type B dissection is initially managed medically. Rupture, malperfusion, extension, progressive enlargement, intractable pain or uncontrolled hypertension identify complications that can require intervention. When anatomy is suitable, an endovascular approach is often favored for relevant descending aortic indications. The decisive distinction is therefore complicated versus uncomplicated disease, not simply the absence of ascending involvement. Repeated clinical and imaging assessment is necessary because an initially uncomplicated presentation can evolve.
Apply it
A patient with descending-only dissection develops abdominal pain, rising lactate and evidence of mesenteric malperfusion despite blood-pressure treatment. Reclassify the problem as complicated and arrange urgent aortic intervention assessment rather than continuing surveillance alone.
Common pitfall: Do not equate all type B disease with safe medical treatment. Organ ischemia or rupture fundamentally changes the management problem despite unchanged anatomic classification.
2022 ACC/AHA Aortic Disease Guideline: Key Perspectives, Part 2
45.How does anti-impulse therapy reduce aortic wall stress?
Anti-impulse therapy reduces the rate and force of ventricular ejection as well as blood pressure, limiting stress on the injured aortic wall. Intravenous beta blockade is the initial approach when not contraindicated; vasodilators can be added if pressure remains excessive. Starting a vasodilator alone may provoke reflex tachycardia. The 2022 guidance targets heart rate 60–80 beats/min and systolic pressure below 120 mm Hg or the lowest pressure preserving organ perfusion.
Apply it
A hypertensive patient with acute aortic syndrome is tachycardic but perfusing adequately. Begin appropriate rate control before adding a vasodilator if needed, while avoiding pressure reduction that compromises cerebral, coronary or visceral perfusion during stabilization.
Common pitfall: Do not pursue a numerical pressure target at the expense of organ perfusion. Also avoid vasodilation that leaves reflex tachycardia and impulse stress uncontrolled.
2022 ACC/AHA Aortic Disease Guideline: Key Perspectives, Part 2
46.When can the native aortic valve be preserved during dissection repair?
Acute type A dissection can cause regurgitation by disturbing root support rather than by destroying the valve leaflets. When the root is only partially dissected and the leaflets have no significant pathology, the 2022 guideline favors valve resuspension over replacement. More extensive root destruction, aneurysm or underlying disease may require a different reconstruction. Identify the regurgitation mechanism before deciding that every leaking valve in dissection needs a prosthesis.
Apply it
During type A repair, the surgeon finds intact valve leaflets and commissural support disrupted by limited root dissection. Consider resuspension to restore competence rather than replacing a structurally normal valve solely because preoperative regurgitation was severe.
Common pitfall: Regurgitation severity alone does not determine valve replacement. Leaflet condition, root pathology and the mechanism of lost support govern whether native-valve preservation is appropriate.
2022 ACC/AHA Aortic Disease Guideline: Key Perspectives, Part 2
47.Which findings trigger surgery for a sporadic ascending aortic aneurysm?
Surgery is indicated for symptoms attributable to the aneurysm, diameter ≥5.5 cm, or rapid growth confirmed by tomographic imaging. For a sporadic root or ascending aneurysm, rapid growth means ≥0.5 cm in one year or ≥0.3 cm annually in two consecutive years. Selected patients qualify at smaller diameters. Apply these thresholds to the appropriate disease category and use comparable imaging methods, because differences in acquisition or measurement can imitate biological enlargement.
Apply it
Comparable gated CT measurements increase from 4.6 to 4.9 to 5.2 cm at annual intervals. Growth of 0.3 cm in each of two consecutive years meets the rapid-growth criterion despite a diameter below 5.5 cm.
Common pitfall: Measurement variability is not confirmed growth. Do not transfer sporadic-aneurysm thresholds unchanged to heritable aortopathy or every concomitant valve operation.
2022 ACC/AHA Aortic Disease Guideline: Key Perspectives, Part 1 · 2022 ACC/AHA Aortic Disease Guideline: Key Perspectives, Part 2
48.Why should relatives be assessed after thoracic aortic disease is diagnosed?
Thoracic aortic aneurysm or dissection can reflect heritable disease even without an obvious syndromic appearance. The 2022 guidance recommends family-history assessment and screening aortic imaging for first-degree relatives of affected patients. Genetic evaluation is particularly relevant with syndromic features, family history or early disease. A negative or uninformative genetic result does not automatically remove the need for family imaging, because current testing does not identify every inherited cause of aortic disease.
Apply it
A relatively young patient undergoes repair of an ascending aneurysm without a known syndrome. Obtain a multigenerational history and arrange appropriate first-degree-relative imaging rather than restricting family assessment to those with visible connective-tissue features.
Common pitfall: Do not treat absence of a recognized syndrome as proof of sporadic disease. Familial aortic risk can exist without obvious external physical findings.
2022 ACC/AHA Aortic Disease Guideline: Key Perspectives, Part 1
Cardiac: Congenital Heart Disease5–10%
49.How is significant aortic coarctation defined, and when is intervention recommended?
Section 9.4.1 and Table 37 of the 2022 ACC/AHA aortic guideline define significant coarctation using upper-extremity hypertension or left ventricular hypertrophy plus a qualifying gradient. Hypertension may be demonstrated at rest, on ambulatory monitoring or by a pathological exercise response. Qualifying measurements ordinarily include an arm–leg blood-pressure difference greater than 20 mm Hg, a catheter peak-to-peak gradient greater than 20 mm Hg, or a mean Doppler gradient greater than 20 mm Hg. For catheter or mean Doppler measurements, a gradient greater than 10 mm Hg qualifies when left ventricular systolic function is reduced or substantial collateral flow is present. Intervention by stenting or open repair is recommended for significant native or recurrent coarctation with hypertension.
Apply it
A hypertensive patient with an arm–leg pressure difference of 26 mm Hg meets the hemodynamic significance criterion. A catheter gradient of 14 mm Hg can also qualify when substantial collateral flow is present. Cross-sectional imaging defines the narrowing, collateral vessels and anatomy needed to plan intervention.
Common pitfall: Do not confuse a peak instantaneous Doppler gradient with the specified mean Doppler gradient or catheter peak-to-peak gradient. A modest measured gradient does not exclude important obstruction when reduced ventricular function or collateral flow lowers flow through the narrowed segment. The lower threshold applies to catheter and mean Doppler measurements, not automatically to the arm–leg pressure difference.
50.How should hypertension after coarctation repair be assessed?
Assess upper- and lower-extremity pressures and image the aorta with MRI or CT for recurrent obstruction and repair-site complications. Recurrent narrowing can create a pressure difference between the proximal and distal circulation, while imaging also evaluates aneurysmal change. Significant native or recurrent coarctation with hypertension warrants stenting or surgical repair according to anatomy. Treat hypertension even after successful repair, because removing a structural obstruction does not guarantee normalization of blood pressure.
Apply it
New hypertension and an arm–leg pressure difference after childhood repair require anatomic reassessment rather than antihypertensive escalation alone. Determine whether recurrent obstruction or another repair-site complication is present.
Common pitfall: Prior repair does not exclude recurrent obstruction or aneurysm. Conversely, hypertension alone does not establish recurrent narrowing without appropriate pressure and imaging assessment.
2022 ACC/AHA Aortic Disease Guideline: Key Perspectives, Part 1
51.How can pulmonary regurgitation cause late problems after tetralogy repair?
Repair can relieve right ventricular outflow obstruction while leaving important pulmonary regurgitation. Chronic regurgitant volume loads the right ventricle and can lead to dilation, impaired function, reduced exercise capacity and arrhythmia concerns. Residual obstruction can also persist or develop, so follow-up must assess both pressure and volume loading. Successful childhood repair therefore changes the physiology but does not eliminate the need for lifelong evaluation of the right ventricular outflow tract and ventricle.
Apply it
An adult repaired in childhood develops declining exercise tolerance and imaging shows severe pulmonary regurgitation with right ventricular enlargement. Evaluate late outflow-tract dysfunction rather than assuming the original repair guarantees normal adult hemodynamics and unrestricted function.
Common pitfall: Do not assess repaired tetralogy only for recurrent stenosis. Regurgitation can impose a major long-term ventricular burden even when forward outflow appears unobstructed.
AHA Long-Term Management of RVOT Dysfunction in Repaired Tetralogy of Fallot
52.How does bicuspid aortic valve disease change aortic operative planning?
Bicuspid aortic valve disease can involve both the valve and the root or ascending aorta. Under 2022 guidance, aortic replacement is recommended at ≥5.5 cm and is reasonable at 5.0–5.4 cm with a dissection risk factor. Concomitant aortic replacement is reasonable at ≥4.5 cm during surgical aortic valve repair or replacement. Assess the complete proximal aorta rather than treating valve dysfunction as the only lesion.
Apply it
A patient undergoing surgery for bicuspid valve stenosis has a 4.7-cm ascending aorta. Discuss concomitant aortic replacement because the setting of planned valve surgery changes the relevant operative threshold.
Common pitfall: The threshold during valve surgery differs from the usual isolated-aorta threshold. Do not interpret a diameter below 5.5 cm as an automatic reason to leave the aorta untreated.
2022 ACC/AHA Aortic Disease Guideline: Key Perspectives, Part 2
Cardiac: General Management10–20%
53.How does sweep gas control carbon dioxide during VV ECMO?
In venovenous ECMO, sweep gas passing through the oxygenator supports carbon dioxide removal. Increasing sweep generally increases carbon dioxide clearance when other conditions are stable. Oxygenation depends more strongly on extracorporeal blood flow relative to cardiac output, oxygenator performance and the patient's circulation. Distinguish these controls when troubleshooting. Avoid abrupt correction of substantial hypercapnia because rapid carbon dioxide changes can have important physiologic consequences, particularly during initiation of extracorporeal support.
Apply it
A VV ECMO patient has rising carbon dioxide with stable oxygenation and adequate circuit blood flow. Assess gas delivery and consider a controlled sweep adjustment rather than increasing blood flow solely to address isolated carbon dioxide retention.
Common pitfall: Do not treat sweep and pump flow as interchangeable controls. Their dominant effects differ, and a gas-supply problem may persist despite higher circuit blood flow.
ELSO Guideline for Adult Patients Supported with Venovenous ECMO, 2021
54.Why can VV ECMO recirculation impair oxygenation?
Recirculation occurs when oxygenated blood returned by the ECMO circuit is drawn back into the drainage cannula before contributing effectively to systemic oxygen delivery. It can produce unexpectedly oxygen-rich drainage blood with inadequate arterial oxygenation despite substantial displayed circuit flow. Cannula position and the relationship between drainage and return streams matter. Assess the configuration and physiology before assuming that simply raising pump speed will increase effective support delivered to the patient.
Apply it
After a cannula shift, drainage blood becomes unusually bright while arterial saturation falls. Evaluate for recirculation and reassess cannula position instead of interpreting the high displayed blood-flow value as proof of adequate systemic support.
Common pitfall: Do not equate total circuit flow with useful oxygenated flow reaching the patient. Recirculated blood can inflate the apparent support without correcting systemic hypoxemia.
ELSO Guideline for Adult Patients Supported with Venovenous ECMO, 2021
55.Why is new heart block during aortic valve endocarditis an urgent finding?
New conduction block can signal infection extending beyond the valve into periannular tissue near the conduction system. Assess urgently for abscess or destructive extension, including transesophageal echocardiography. Endocarditis complicated by heart block or annular or aortic abscess is an indication for early surgery during the initial hospitalization, before completion of antibiotics. Rhythm stabilization and assessment for pacing needs accompany infection source control, because bradycardia treatment alone does not remove infected tissue.
Apply it
A patient receiving antibiotics for aortic valve endocarditis develops complete heart block. Arrange urgent rhythm support, evaluation for periannular extension and surgical assessment.
Common pitfall: Pacing can stabilize bradycardia but does not eradicate an invasive infection. Do not wait for antibiotic completion to investigate the new block.
2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 3
56.How should postoperative platelet patterns and laboratory tests be integrated when assessing HIT?
Use the 4Ts framework to assess platelet decline, timing, thrombosis and alternative causes before ordering and interpreting tests. A second substantial fall after initial recovery following bypass is more concerning than the expected immediate postoperative decline. A clinically important percentage fall can occur while the absolute count remains normal. Immunoassays detect antibodies against platelet factor 4–heparin complexes; functional assays assess platelet activation. Antibody positivity alone, particularly after cardiac surgery, does not establish clinical HIT.
Apply it
After initial platelet recovery, a patient develops a second fall and thrombosis. Establish clinical probability and obtain appropriate testing; interpret an antibody result in that context rather than equating positivity with platelet-activating disease.
Common pitfall: Neither an isolated postoperative low count nor an isolated positive immunoassay is sufficient. Timing, percentage decline, thrombosis and assay purpose must agree with the clinical assessment.
ASH Diagnosis and Management of Heparin-Induced Thrombocytopenia
57.When should expected benefit redirect a valve intervention discussion toward palliative care?
Technical feasibility does not establish that valve intervention will provide meaningful benefit. The 2020 ACC/AHA framework recommends palliative care after shared decision-making when predicted survival after TAVI is less than 12 months or minimal improvement in quality of life is expected. Discuss prognosis, symptom goals, treatment burden and the patient's priorities. Palliative care remains active symptom-focused treatment and support, rather than abandonment of care.
Apply it
A patient with symptomatic severe stenosis has advanced noncardiac disease, predicted post-TAVI survival of 6 months and little expected functional improvement. Explain the limited benefit and develop a symptom-focused plan through shared decision-making.
Common pitfall: Do not equate high surgical risk with automatic benefit from a transcatheter procedure or use age alone to decide that treatment is futile.
2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 1
58.Why does confirmed HIT require more than stopping heparin?
Confirmed acute HIT carries substantial thrombosis risk despite the falling platelet count. Management requires stopping heparin exposure and starting an appropriate non-heparin anticoagulant unless a specific clinical contraindication changes the immediate plan. Agent selection depends on clinical stability, organ function and procedural needs. Starting a vitamin K antagonist before platelet recovery is inappropriate; if already present, reversal may be required. The central mechanism is pathologic platelet activation and thrombosis, not isolated failure of platelet production.
Apply it
A patient has confirmed HIT with a new venous thrombosis and no active major bleeding. Stop heparin and begin a suitable non-heparin anticoagulant rather than waiting for the platelet count to normalize before providing thrombosis treatment.
Common pitfall: Do not treat the low platelet count as protection from clotting. Stopping heparin alone leaves the patient exposed to ongoing immune-mediated thrombotic risk.
ASH Diagnosis and Management of Heparin-Induced Thrombocytopenia
59.How should restrictive transfusion be applied after cardiac surgery?
The 2021 cardiac-surgery blood-management guideline supports restrictive red-cell transfusion to reduce transfusion exposure without increasing major morbidity or mortality in the studied populations. An operational example is TRICS III: its restrictive strategy used hemoglobin below 7.5 g/dL as the transfusion trigger in adults at moderate-to-high operative risk undergoing cardiac surgery with cardiopulmonary bypass. This provides a concrete evidence-based strategy, while the patient's bleeding, ischemia, hemodynamics and tissue perfusion remain essential to individual decisions.
Apply it
A stable postoperative patient with hemoglobin 7.8 g/dL, no active bleeding and adequate perfusion would not receive red cells solely to normalize hemoglobin under the TRICS III restrictive strategy. A value below 7.5 g/dL reaches that trial's restrictive trigger.
Common pitfall: Do not wait mechanically for a numerical threshold during active hemorrhage, myocardial ischemia or inadequate oxygen delivery. Acute blood loss may require resuscitation and source control before hemoglobin fully reflects the loss. Conversely, stable postoperative anemia does not justify transfusion to a normal concentration.
STS/SCA/AmSECT/SABM Patient Blood Management Guideline Update, 2021
60.What does centrifugation-based cell salvage restore during cardiac surgery?
Centrifugation-based cell salvage recovers and processes shed blood to return concentrated autologous red cells, reducing reliance on donor red-cell transfusion. The 2021 guideline supports routine use in cardiac operations using cardiopulmonary bypass. The processed product does not replace all components of whole blood: clinically important platelet or coagulation-factor deficits require separate assessment. Distinguish restoration of oxygen-carrying red-cell mass from correction of the full hemostatic disturbance in a bleeding patient.
Apply it
During bypass surgery, salvaged red cells are returned but diffuse bleeding persists. Evaluate coagulation and surgical sources rather than assuming the autologous red-cell return has also restored platelet function and plasma coagulation factors sufficiently.
Common pitfall: Do not call processed cell-salvage blood complete whole-blood replacement. Its red-cell benefit does not establish correction of thrombocytopenia, platelet dysfunction or factor deficiency.
STS/SCA/AmSECT/SABM Patient Blood Management Guideline Update, 2021
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Map anatomy to decisions: nodal stations, thoracic inlet invasion, airway reconstruction, diaphragm defects and aortic involvement.
- Separate technical resectability, oncologic appropriateness and physiologic operability in lung cancer.
- Distinguish infected pleural collections, malignant effusions with non-expandable lung and recurrent spontaneous pneumothorax.
- Recognize when antibiotics, defect closure or a functioning drain still leave inadequate source control.
- Use disease-specific valve criteria, prosthesis-specific anticoagulation targets and defined aortic growth thresholds.
- Connect conduit choice to target stenosis, donor-limb safety and sternal wound risk.
- Compare late tetralogy physiology with coarctation complications and bicuspid valve aortopathy.
- Distinguish sweep-controlled carbon dioxide clearance from effective extracorporeal blood flow and recirculation.
- Interpret postoperative thrombocytopenia through timing, percentage fall, thrombosis and assay purpose.
- Recognize invasive infection behind new conduction block and connect intervention choices to expected survival, quality of life and patient goals.
- Extend study to the complete official outline, including additional congenital lesions, pacing, myocardial protection, transplantation, cardiomyopathy and arrhythmia surgery.
A practical preparation plan
1. Build a blueprint-based study map
Use the official ranges to reserve approximately equal study time for General Thoracic and Cardiac. Give Lung and Acquired Heart Disease the largest individual blocks while maintaining regular coverage of every smaller domain.
2. Solve anatomy and mechanism before choosing treatment
For each case, state the lesion, its physiological consequence and the finding that changes management. Practise contrasting hilar with mediastinal disease, contained with freely contaminating perforation, and primary with secondary mitral regurgitation.
3. Create a criteria notebook
Record supported thresholds with their disease context and reference year. Include pleural infection drainage, primary mitral ventricular thresholds, selected secondary mitral repair criteria, mechanical-valve INR targets and defined aortic growth triggers. Keep edition-sensitive staging separate and use the current ABTS ninth-edition notice.
4. Practise interpretation and calculations
Show assumptions and units for split-function estimates. Explain why a trial endpoint, PET result, HIT antibody test or ECMO flow measurement can be misinterpreted when detached from its clinical context.
5. Use the questions to diagnose reasoning gaps
Complete the 20 independent questions before reviewing explanations. For each error, identify the missed decisive cue and explain why each alternative fails. Use the flashcards later to recall the mechanism without recognizing an answer list.
6. Expand to full specialty scope
Return to formal cardiothoracic textbooks, journals and courses for omitted topics and deeper operative detail. Build mixed timed practice around the published two-section format while treating this small question set as formative learning rather than a pass prediction.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ABTS Training and Initial Certification
- ABTS Written Exam Blueprint
- ABTS Primary Certification Part I (Written) Examination
- ABTS Examination Sequence
- NCI Non-Small Cell Lung Cancer Treatment: Health Professional Version
- NCI Non-Small Cell Lung Cancer Treatment: Patient Version
- Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
- ESTS Announcement of the ERS/ESTS Lung Cancer Fitness Guideline
- Thoracic Trauma WSES-AAST Guidelines
- British Thoracic Society Guideline for Pleural Disease, July 2023
- NCI Thymoma and Thymic Carcinoma Treatment
- Esophageal Emergencies: WSES Guidelines, 2019
- ACG Clinical Guidelines: Diagnosis and Management of Achalasia, 2020
- STS Clinical Practice Guidelines on Arterial Conduits for CABG, 2016
- 2022 ACC/AHA Aortic Disease Guideline: Key Perspectives, Part 2
- 2022 ACC/AHA Aortic Disease Guideline: Key Perspectives, Part 1
- 2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 1
- 2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 2
- 2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 3
- ACC Guidelines and Clinical Policy
- CDC Tetralogy of Fallot
- AHA Long-Term Management of RVOT Dysfunction in Repaired Tetralogy of Fallot
- ELSO Guideline for Adult Patients Supported with Venovenous ECMO, 2021
- ELSO Guidelines
- ASH Diagnosis and Management of Heparin-Induced Thrombocytopenia
- STS/SCA/AmSECT/SABM Patient Blood Management Guideline Update, 2021
- STS Clinical Practice Documents and Policies
- Client Challenge
- 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines - PMC
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.